Exercise price
As seen in:
ADVFN,
ADVFN-UK,
This is Money,
MarketScreener,
FE Investegate,
MFN.se,
klsescreener.com
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Exercise price
CEB - OTHERS
We refer to the SIS which was approved by the shareholders of CEB at the Extraordinary General Meeting held on 1 August 2025. Pursuant to Paragraph 9.19(51) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of CEB wishes to announce that the options offerred under the SIS are as follows:- 1. Date of offer 22 September 2026 2. Exercise price of SIS options offered RM0.2588 3. Number of SIS options offered 148,800,000 4.
Richmond Hill Resources Plc - Grant of Options
Richmond Hill Resources PLC ("Richmond Hill" or the "Company") Grant of Options Richmond Hill Resources PLC (AIM: RHR) announces the grant of options to certain directors of the Company. Grant of Options Options over a total of 31,000,000 new ordinary shares in the Company ("Ordinary Shares") were awarded on 27 April 2026 at an exercise price of 2 pence per new Ordinary Share (being a premium of approximately 30 per cent over the mid closing price on 24 April 2026) (the "Options").
Restructuring of executive share incentives
Sosandar plc ("Sosandar" or the "Company") Restructuring of executive share incentives Sosandar, the women's fashion brand, creating quality, trend-led products for women of all ages, announces that it has restructured an element of its share incentive scheme.
Atlantic Sapphire ASA: Commencement of first exercise period for warrants
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to previously announced information about the warrants issued by the Company, with ISIN NO 001 3340802 and traded on Euronext Oslo Børs under ticker code "ASAS" (the "Warrants").
Issue of EMI Options | Company Announcement | Investegate
Oberon Investments Group PLC ("Oberon Investments" or the "Company") Issue of EMI Options Oberon Investments Group plc announces the grant on 24 October 2025 of EMI options over 9,194,341 Ordinary shares of 0.5p each in Oberon Investments Group plc (the 'Options') to two directors and other members of staff. These EMI options have an exercise price in a range of between 3.8p and 4.5p per share.
EXERCISE OF STOCK OPTIONS, ISSUE OF EQUITY & PDMR
Cornish Metals Inc. announced that Non-Executive Chairman Patrick F. N. Anderson exercised 750,000 stock options at 10 cents per common share, resulting in an aggregate consideration of C$75,000 (approximately £40,079). Following this transaction, Anderson's beneficial interest in the company is 1,425,271 common shares, representing 0.11% of the issued share capital.
Exercise of Warrants and Total Voting Rights
Oriole Resources PLC ("Oriole Resources" or the "Company") Exercise of Warrants and Total Voting Rights Oriole Resources PLC (AIM: ORR), the AIM quoted gold exploration company focussed on West and Central Africa announces that, following an exercise of warrants over ordinary shares in the Company application has been made for 2,330,000 new ordinary shares of 0.1p each ("Ordinary Shares") in the Company to be admitted to trading on AIM on 5 September 2025 ("Admission").
Coral Products PLC Issue of Options
Register to chat with like-minded investors on our interactive forums.
Issue of Options
Coral Products PLC 08 July 2025 Coral Products Plc ("CRU" or the "Company") Issue of Options Coral Products plc, a group of specialist businesses in the design, UK manufacture and omni-channel supply of a wide range of bespoke plastic products based in Wythenshawe, Manchester, announces that as part of the Company's long-term incentive framework, the Company has granted 10,000,000 options over new ordinary shares of 1 pence each ("Ordinary Shares") in the Company ("Options") to certain...
Final Results & Klarian Update
RNS Number : 8655O Catenai PLC 30 June 2025 30 June 2025 Catenai PLC ("Catenai" or the "Company") Final Results & Klarian Update Catenai PLC (AIM: CTAI), the AIM quoted provider of digital media and technology, announces its full year audited results for the year ended 31 December 2024. Financial overview · The Company made a net loss for the year of £128,174 (2023: £261,318). Revenues for the year were £131,500 (2023: £28,670).
Final Results, 25 Jun 2025 09:30
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
Nostra Terra Oil & Gas Company PLC 2024 Audited Annual Results & Notice of AGM
2024 - Continued change and intensified focus. During 2024 crude oil prices including WTI, the benchmark against which Nostra Terra's production is sold, continued on a generally falling trajectory. Russian oil production continues to find its way to market, often at discounted prices; both the volume and price effects of this and continued concerns over the health of the global economy are in part to blame for this price weakness.
Brooks Macdonald Group PLC Grant of SAYE Options
Register for streaming realtime charts, analysis tools, and prices.
Grants of Options & PDMR dealings
Itaconix PLC 07 April 2025 For release 7 April 2025 Itaconix plc ("Itaconix" or the "Company") Grants of Options & PDMR dealings Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, announces a grant of options to certain PDMRs. On 7 April 2025, a total of 66,500 options over ordinary shares of £0.50 in the Company ("Options") were granted under the Company's employee share option plan.
Invinity Energy Systems PLC Changes to Option Terms
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Emmerson PLC Grant of Share Options and PDMR dealing
Register to chat with like-minded investors on our interactive forums.
Grant of Share Options and PDMR dealing
Emmerson PLC / Ticker: EML / Index: AIM / Sector: Mining 31 May 2024 Emmerson PLC ("Emmerson" or the "Company") Grant of Share Options and PDMR dealing Emmerson, the Moroccan focused potash development company, announces the award of share options and PDMR dealing.
Bradda Head Lithium Ltd Unaudited Interim Results for the 9 and 3 Months (4659A)
Register for real-time alerts, custom portfolio, and market movers Share Name Share Symbol Market Type Share ISIN Share Description Bradda Head Lithium Limited LSE:BHL London Ordinary Share VGG154091083 ORD NPV (DI) Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 0.00 0.0% 1.60 1.50 1.70 1.65 1.60 1.65 11,842 08:01:40 Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap Metal Mining Services 4.52M -3.89M -0.0100 -1.60...
Preliminary Results and Notice of AGM
Oxford Biodynamics Plc ("OBD" or the "Company" and, together with its subsidiaries, the "Group") Preliminary results for the year ended 30 September 2023 and Notice of Annual General Meeting Oxford, UK - 17 January 2024 - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, today announces its final results for the year ended 30 September 2023.
Final Results | Company Announcement | Investegate
As at 31 December 2024 £'000 As at 31 December 2023 £'000 Cash flows from operating activities Loss before taxation (471) (631) Adjustments for: Fair value adjustment for listed investments 37 61 Share based payments 27 61 (Increase) in trade and other receivables (218) (286) (Decrease)/increase in trade and other payables (5) 56 Net cash used in operating activities (630) (739) Cashflows from investing activities Purchase of investment in subsidiaries - (500) Net Cash flows from investing...
Board Change, Subscription and Option Exercise
RNS Number : 7187W Unicorn Mineral Resources plc 14 December 2023 14 December 2023 Unicorn Mineral Resources Plc ("Unicorn" or the "Company") Appointment of Jason Brewer as an Executive Director ("Appointment") Subscription to raise c£573,000 ("Subscription") Exercise of 900,000 Options ("Option Exercise") Unicorn Mineral Resources Plc (LSE:UMR), a mineral exploration and development company based in Ireland exploring for Zinc, Lead, Copper and Silver with its main focus at present being the...
Bradda Head Lithium Ltd Unaudited Interim Results (2334R)
Register for real-time alerts, custom portfolio, and market movers Share Name Share Symbol Market Type Share ISIN Share Description Bradda Head Lithium Limited LSE:BHL London Ordinary Share VGG154091083 ORD NPV (DI) Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 0.00 0.0% 2.40 2.40 2.70 0.00 01:00:00 Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) Metal Mining Services 4.5 -3.9 -1.0 - 9.37 Bradda...
HeiQ PLC Accounts Update (0824O)
Heiq (LSE:HEIQ) Intraday Stock Chart Friday 29 September 2023 TIDMHEIQ RNS Number : 0824O HeiQ PLC 29 September 2023 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.
Marula Mining Plc Exercise of Warrants, Issue of Equity, Director/PDMR Dealing
Share Name Share Symbol Market Type Share ISIN Share Description Marula Mining PLC AQSE:MARU Aquis Stock Exchange Ordinary Share GB00BNBS4S95 Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade -0.50 -3.39% 14.25 14.00 15.00 14.75 13.875 14.75 636,317 16:29:57 Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) - - - - TIDMMARU Marula Mining PLC ("Marula" or the "Company") 1 September 2023 Exercise of...
Bradda Head Lithium Ltd Unaudited Results for 3 months ended 31 May 2023
Bradda Head Lithium (LSE:BHL) Intraday Stock Chart Thursday 31 August 2023 TIDMBHL RNS Number : 9714K Bradda Head Lithium Ltd 31 August 2023 31 August 2023 Bradda Head Lithium Ltd ("Bradda Head", "Bradda", or the "Company") Unaudited Interim Results for the three months ended 31 May 2023 Bradda Head Lithium Ltd (AIM: BHL), the North America-focused lithium development group, is pleased to announce that it has today published its unaudited financial results for the three months ended 31 May...
Director/PDMR Shareholding
RNS Number : 4898K Record PLC 25 August 2023 25 August 2023 Record plc ('Record' or the 'Company') Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulation The Company announces, in accordance with DTR 3.1.4R(1) that on 23 August 2023 the following directors of the Company (each a person discharging managerial responsibilities) and persons closely associated...
ISSUE OF WARRANTS
11 August 2023 SUNRISE RESOURCES PLC ("Sunrise" or "the Company") ISSUE OF WARRANTS Sunrise Resources plc wishes to announce as follows: Issue of Employee Warrants On Wednesday 9 August 2023, the Board resolved to issue warrants to subscribe for Ordinary Shares in the Company as part of a long-standing annual arrangement as follows: A total of 9,000,0000 warrants over new Ordinary Shares, representing 0.22% of the Company's issued share capital, are being issued to certain employees of...
Marula Mining Plc Warrant Update and Extension and Related Party Transactions
Share Name Share Symbol Market Type Share ISIN Share Description Marula Mining PLC AQSE:MARU Aquis Stock Exchange Ordinary Share GB00BNBS4S95 Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 0.00 0.0% 9.25 0.00 - Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) - - - - Marula Mining Plc Warrant Update and Extension and Related Party Transactions 24/07/2023 9:00am UK Regulatory (RNS & others) TIDMMARU...
20230713_HORIZON THERAPEUTICS PLC_38.5 (b)IE_MLPFS
Source - LSE Regulatory RNS Number : 0987G Bank of America Merrill Lynch 14 July 2023 FORM 38.5(b) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY Name of exempt principal trader MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED HORIZON THERAPEUTICS PLC Class of...
EXERCISE OF STOCK OPTIONS AND ISSUE OF EQUITY
Cornish Metals Inc. announced that Matthew Hird, CFO, exercised 750,000 stock options using the net exercise method, resulting in the issuance of 249,626 new common shares. These shares will rank equally with existing shares, and application has been made for their admission to trading on AIM, expected around October 14, 2025. Subsequently, Mr. Hird sold these 249,626 shares at a price of 7.80 pence per share, with settlement due on the same date; his beneficial interest remains unchanged.
FIRST WAVE BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K) | MarketScreener
Item 1.01 Entry into a Merial Definitive Agreement.
Form 8 (OPD) - Industrials REIT Limited
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
Full Year Results
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
Director/PDMR Shareholding
We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms.
Director/PDMR Shareholding
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
Allergy Therapeutics
We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms.
20230301_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
HORIZON THERAPEUTICS PLC_38.5 (b)_IE_MLPFS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
HORIZON THERAPEUTICS PLC_38.5 (b)_IE_MLPFS
Source - LSE Regulatory RNS Number : 8745Q Bank of America Merrill Lynch 23 February 2023 FORM 38.5(b) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY Name of exempt principal trader MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED HORIZON THERAPEUTICS PLC...
HORIZON THERAPEUTICS PLC_38.5 (b)_IE_MLPFS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
HORIZON THERAPEUTICS PLC_38.5 (b)_IE_MLPFS
Source - LSE Regulatory RNS Number : 4528Q Bank of America Merrill Lynch 20 February 2023 FORM 38.5(b) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY Name of exempt principal trader MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED HORIZON THERAPEUTICS PLC...
20230209_HORIZON THERAPEUTICS PLC_38.5 (b)_MLPFS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
20230208_HORIZON THERAPEUTICS PLC_38.5 (b)_MLPFS
Source - LSE Regulatory RNS Number : 4593P Bank of America Merrill Lynch 09 February 2023 FORM 38.5(b) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY Name of exempt principal trader MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED HORIZON THERAPEUTICS PLC...
Form 8.5 (EPT/NON-RI) - Horizon Therapeutics PLC
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
20230206_HORIZON THERAPEUTICS PLC_38.5 (b)_MLPFS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
20230206_HORIZON THERAPEUTICS PLC_38.5 (b)_MLPFS
Source - LSE Regulatory RNS Number : 1750P Bank of America Merrill Lynch 07 February 2023 FORM 38.5(b) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY Name of exempt principal trader MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED HORIZON THERAPEUTICS PLC...
HORIZON THERAPEUTICS PLC_38.5 (b)_IE_MLPFS
Source - LSE Regulatory RNS Number : 5937O Bank of America Merrill Lynch 01 February 2023 FORM 38.5(b) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY Name of exempt principal trader MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED HORIZON THERAPEUTICS PLC...
20230112_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms.
20230112_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
HORIZON THERAPEUTICS PLC_38.5 (b)_IE_MLPFS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit www.rns.com.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Exercise
Contact Exercise, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack